Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
Measurement of alveolar nitric oxide in patients with lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
L-Arginine is not the limiting factor for nitric oxide synthesis by human alveolar macrophages in vitro Source: Eur Respir J 2001; 18: 667-671 Year: 2001
Prognostic evaluation of alveolar concentration of nitric oxide, serum periostin and CD59 in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
Increased exhaled nitric oxide precedes lung fibrosis in a murine model of systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Increased alveolar concentrations of exhaled nitric oxide (NO) are associated with lung affection in systemic sclerosis (SSc) Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005
Effects of chronic nitric oxide inhibition on eosinophil recruitment and extracellular matrix remodelling in chronic pulmonary inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 735s Year: 2007
Increased alveolar and bronchial nitric oxide output in patients with asthmatic symptoms but normal lung function Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007
iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003
Nitric oxide (NO) modulates ICAM-1 expression and function and MCP-1 secretion in human airway epithelium Source: Eur Respir J 2005; 26: Suppl. 49, 99s Year: 2005
Nitric oxide modulates expression of matrix metalloproteinase-2 in asthmatic rats: a role in airway remodeling Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
Inducible nitric oxide synthase inhibition reduces eosinophilic and lymphocytic recruitment to lung parenchyma in guinea pigs with chronic pulmonary inflammation Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007
Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 432s Year: 2006
Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003
Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016
Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs Source: ERJ Open Res 2016 Year: 2016